BIRC5 and ovarian carcinoma: Reflecting its well-established role in the chemoresistance of various human cancers including ovarian cancer, FOXM1 has a variety of transcriptional targets in addition to BIRC5/survivin that can contribute to the chemoresistance phenotype at multiple levels such as DNA repair, drug efflux, and microtubule dynamics [8].